148 related articles for article (PubMed ID: 18292499)
1. 1,25-dihydroxyvitamin D3 induces CCR10 expression in terminally differentiating human B cells.
Shirakawa AK; Nagakubo D; Hieshima K; Nakayama T; Jin Z; Yoshie O
J Immunol; 2008 Mar; 180(5):2786-95. PubMed ID: 18292499
[TBL] [Abstract][Full Text] [Related]
2. Polymeric IgA-secreting and mucosal homing pre-plasma cells in normal human peripheral blood.
Fernandes JR; Snider DP
Int Immunol; 2010 Jun; 22(6):527-40. PubMed ID: 20497956
[TBL] [Abstract][Full Text] [Related]
3. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
4. An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts.
Veenstra TD; Fahnestock M; Kumar R
Biochemistry; 1998 Apr; 37(17):5988-94. PubMed ID: 9558335
[TBL] [Abstract][Full Text] [Related]
5. 1,25-Dihydroxyvitamin D3 up-regulates TLR10 while down-regulating TLR2, 4, and 5 in human monocyte THP-1.
Verma R; Jung JH; Kim JY
J Steroid Biochem Mol Biol; 2014 May; 141():1-6. PubMed ID: 24373795
[TBL] [Abstract][Full Text] [Related]
6. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
Kim S; Shevde NK; Pike JW
J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
[TBL] [Abstract][Full Text] [Related]
7. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element.
Uchida M; Ozono K; Pike JW
J Bone Miner Res; 1994 Dec; 9(12):1981-7. PubMed ID: 7872065
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion.
Lee S; Clark SA; Gill RK; Christakos S
Endocrinology; 1994 Apr; 134(4):1602-10. PubMed ID: 8137721
[TBL] [Abstract][Full Text] [Related]
9. Requirements for induction of vitamin D-mediated gene regulation in normal human B lymphocytes.
Morgan JW; Morgan DM; Lasky SR; Ford D; Kouttab N; Maizel AL
J Immunol; 1996 Oct; 157(7):2900-8. PubMed ID: 8816395
[TBL] [Abstract][Full Text] [Related]
10. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
Chow EC; Quach HP; Vieth R; Pang KS
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
[TBL] [Abstract][Full Text] [Related]
11. 1,25-dihydroxyvitamin D3 induction of nerve growth factor in L929 mouse fibroblasts: effect of vitamin D receptor regulation and potency of vitamin D3 analogs.
Musiol IM; Feldman D
Endocrinology; 1997 Jan; 138(1):12-8. PubMed ID: 8977379
[TBL] [Abstract][Full Text] [Related]
12. Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3.
Demay MB; Kiernan MS; DeLuca HF; Kronenberg HM
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8097-101. PubMed ID: 1325645
[TBL] [Abstract][Full Text] [Related]
13. Functional block for 1 alpha,25-dihydroxyvitamin D3-mediated gene regulation in human B lymphocytes.
Morgan JW; Reddy GS; Uskokovic MR; May BK; Omdahl JL; Maizel AL; Sharma S
J Biol Chem; 1994 May; 269(18):13437-43. PubMed ID: 8175775
[TBL] [Abstract][Full Text] [Related]
14. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system.
Baeke F; Korf H; Overbergh L; van Etten E; Verstuyf A; Gysemans C; Mathieu C
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):221-7. PubMed ID: 20302932
[TBL] [Abstract][Full Text] [Related]
15. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
Meyer MB; Watanuki M; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1447-61. PubMed ID: 16574738
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of vitamin D responsive elements in normal and transformed keratinocytes.
Xie Z; Bikle DD
J Invest Dermatol; 1998 May; 110(5):730-3. PubMed ID: 9579536
[TBL] [Abstract][Full Text] [Related]
17. Pro-inflammatory signaling by 24,25-dihydroxyvitamin D3 in HepG2 cells.
Wehmeier K; Onstead-Haas LM; Wong NC; Mooradian AD; Haas MJ
J Mol Endocrinol; 2016 Aug; 57(2):87-96. PubMed ID: 27234962
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription.
Blanco JC; Wang IM; Tsai SY; Tsai MJ; O'Malley BW; Jurutka PW; Haussler MR; Ozato K
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1535-9. PubMed ID: 7878015
[TBL] [Abstract][Full Text] [Related]
19. 1α,25-Dihydroxyvitamin D
Ishizawa M; Akagi D; Yamamoto J; Makishima M
J Steroid Biochem Mol Biol; 2017 Sep; 172():55-61. PubMed ID: 28578001
[TBL] [Abstract][Full Text] [Related]
20. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
